» Articles » PMID: 22786591

Contributions of Vitamin D Response Elements and HLA Promoters to Multiple Sclerosis Risk

Overview
Journal Neurology
Specialty Neurology
Date 2012 Jul 13
PMID 22786591
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The identification of a vitamin D-responsive (VDRE) motif within the HLA-DRB1*15:01 promoter region provides an attractive explanation for the combined effects of HLA-DR inheritance and vitamin D exposure on multiple sclerosis (MS) risk. We therefore sought to incorporate HLA-DRB1 promoter variation, including the VDRE motif, in an assessment of HLA-DRB1-associated MS risk.

Methods: We utilized 32 homozygous HLA cell lines (covering 17 DRB1 alleles) and 53 heterozygote MS samples (20 DRB1 alleles) for HLA-DRB1 promoter sequencing. The influence of HLA-DRB1 variation on MS risk was then assessed among 466 MS cases and 498 controls.

Results: The majority of HLA*DRB1 alleles (including HLA-DRB1*15:01) express the functional VDRE motif, apart from HLA-DRB1*04, *07, and *09 alleles that comprise the HLA-DR53 serologic group. Allele-specific variation within functional X-box and Y-box motifs was also associated with serologically defined HLA-DR haplotypes. Incorporating these results in an analysis of MS risk, we identified a strong protective effect of HLA-DRB1*04, *07, and *09 (DR53) alleles (p = 10(-12)) and elevated risk associated with DRB1*15 and *16 (DR51) and *08 (DR8) alleles (p < 10(-18)).

Conclusions: HLA-DRB1 groups corresponding to serologic HLA-DR profiles as well as promoter polymorphism haplotypes effectively stratified MS risk over an 11-fold range, suggesting functional relationships between risk-modifying HLA-DRB1 alleles. An independent contribution of VDRE motif variation to increase MS risk was not discernible, although vitamin D-dependent regulation of HLA-DR expression may still play an important role given that HLA-DRB1*04/*07/*09 (DR53) alleles that express the "nonresponsive" VDRE motif were associated with significantly reduced risk of MS.

Citing Articles

Epstein-Barr virus as a potentiator of autoimmune diseases.

Robinson W, Younis S, Love Z, Steinman L, Lanz T Nat Rev Rheumatol. 2024; 20(11):729-740.

PMID: 39390260 DOI: 10.1038/s41584-024-01167-9.


Is multiple sclerosis progression associated with the HLA-DR15 haplotype?.

Sturner K, Siembab I, Schon G, Stellmann J, Heidari N, Fehse B Mult Scler J Exp Transl Clin. 2019; 5(4):2055217319894615.

PMID: 31839982 PMC: 6902395. DOI: 10.1177/2055217319894615.


The genetic diversity of multiple sclerosis risk among Hispanic and African American populations living in the United States.

Beecham A, Amezcua L, Chinea A, Manrique C, Rubi C, Isobe N Mult Scler. 2019; 26(11):1329-1339.

PMID: 31368393 PMC: 6994382. DOI: 10.1177/1352458519863764.


HLA alleles modulate EBV viral load in multiple sclerosis.

Agostini S, Mancuso R, Guerini F, DAlfonso S, Agliardi C, Hernis A J Transl Med. 2018; 16(1):80.

PMID: 29587799 PMC: 5870171. DOI: 10.1186/s12967-018-1450-6.


Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.

Tschochner M, Leary S, Cooper D, Strautins K, Chopra A, Clark H PLoS One. 2016; 11(2):e0147567.

PMID: 26849221 PMC: 4744032. DOI: 10.1371/journal.pone.0147567.